1. An agenda for personalized medicine;Ng;Nature,2009
2. The path to personalized medicine;Hamburg;N. Engl. J. Med.,2010
3. Phase iii randomized, open-label, multicenter trial (brim3) comparing braf inhibitor vemurafenib with dacarbazine (dtic) in patients with v600ebraf-mutated melanoma;Chapman;J. Clin. Oncol.,2011
4. N. Scholz, Personalised medicine; The right treatment for the right person at the right time, Technical Report, 2015. URL: http://www.europarl.europa.eu/RegData/etudes/BRIE/2015/569009/EPRS_BRI(2015)569009_EN.pdf.
5. Health literacy screening instruments for ehealth applications: a systematic review;Collins;J. Biomed. Inform.,2012